Hemoglobin, Volume 33, Issue 5 (2009)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Hemoglobin, Volume 33, Issue 5 (2009)

See all volumes and issues
Vol 48, 2024 Vol 47, 2023 Vol 46, 2022 Vol 45, 2021 Vol 44, 2020 Vol 43, 2019 Vol 42, 2018 Vol 41, 2017 Vol 40, 2016 Vol 39, 2015 Vol 38, 2014 Vol 37, 2013 Vol 36, 2012 Vol 35, 2011 Vol 34, 2010 Volume 33, 2009 Vol 32, 2008 Vol 31, 2007 Vol 30, 2006 Vol 29, 2005 Vol 28, 2004 Vol 27, 2003 Vol 26, 2002 Vol 25, 2001 Vol 24, 2000 Vol 23, 1999 Vol 22, 1998 Vol 21, 1997 Vol 20, 1996 Vol 19, 1995 Vol 18, 1994 Vol 17, 1993 Vol 16, 1992 Vol 15, 1991 Vol 14, 1990 Vol 13, 1989 Vol 12, 1988 Vol 11, 1987 Vol 10, 1986 Vol 9, 1985 Vol 8, 1984 Vol 7, 1983 Vol 6, 1982 Vol 5, 1981 Vol 4, 1980 Vol 3, 1979 Vol 2, 1978 Vol 1, 1976-1977
Download citations Download PDFs Download issue

PROCEEDINGS 17TH ICOC Shenzhen, PR China, November 2007

Article
The Proceedings of the 17th International Conference on Chelation: Application of Effective Chelation Therapies in Iron Loading and Non Iron Loading Conditions, and the Gap in the Prevention and Treatment Policies on Thalassemia Between Developed and Developing Countries
George J. Kontoghiorghes
Pages: 283-286
Published online: 09 Oct 2009
AbstractforThe Proceedings of the 17th International Conference on Chelation: Application of Effective Chelation Therapies in Iron Loading and Non Iron Loading Conditions, and the Gap in the Prevention and Treatment Policies on Thalassemia Between Developed and Developing Countries | Full Text | PDF (68.3 KB)
  • 58 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Advances in the Prevention and Treatment are Changing Thalassemia from a Fatal to a Chronic Disease. Experience from a Cyprus Model and its Use as a Paradigm for Future Applications
Anita Kolnagou & George J. Kontoghiorghes
Pages: 287-295
Published online: 09 Oct 2009
AbstractforAdvances in the Prevention and Treatment are Changing Thalassemia from a Fatal to a Chronic Disease. Experience from a Cyprus Model and its Use as a Paradigm for Future Applications | Full Text | References | PDF (99.3 KB)
  • 162 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Thalassemia Incidence and Treatment in China with Special Reference to Shenzhen City and Guangdong Province
Chang-Gang Li, Chun-Fu Li, Qi Li & Ming Li
Pages: 296-303
Published online: 09 Oct 2009
AbstractforThalassemia Incidence and Treatment in China with Special Reference to Shenzhen City and Guangdong Province | Full Text | References | PDF (96 KB)
  • 231 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
Update on Thalassemia Treatment in Taiwan, Including Bone Marrow Transplantation, Chelation Therapy, and Cardiomyopathy Treatment Effects
Ching-Tien Peng, Jeng-Sheng Chang, Lin-Yen Wang, Shyh-Shin Chiou, Chih-Cheng Hsiao, Shih-Chung Wang, Giun-Yi Hung & Kang-Hsi Wu
Pages: 304-311
Published online: 09 Oct 2009
AbstractforUpdate on Thalassemia Treatment in Taiwan, Including Bone Marrow Transplantation, Chelation Therapy, and Cardiomyopathy Treatment Effects | Full Text | References | PDF (155.4 KB)
  • 173 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Uses and Limitations of Serum Ferritin, Magnetic Resonance Imaging T2 and T2* in the Diagnosis of Iron Overload and in the Ferrikinetics of Normalization of the Iron Stores in Thalassemia Using the International Committee on Chelation Deferiprone/Deferoxamine Combination Protocol
Anita Kolnagou, Dilek Yazman, Charalambos Economides, Eleni Eracleous & George J. Kontoghiorghes
Pages: 312-322
Published online: 09 Oct 2009
AbstractforUses and Limitations of Serum Ferritin, Magnetic Resonance Imaging T2 and T2* in the Diagnosis of Iron Overload and in the Ferrikinetics of Normalization of the Iron Stores in Thalassemia Using the International Committee on Chelation Deferiprone/Deferoxamine Combination Protocol | Full Text | References | PDF (254.3 KB)
  • 222 Views
  • 27 CrossRef citations
  • 0Altmetric
Article
A Practical Chelation Protocol Based on Stratification of Thalassemic Patients by Serum Ferritin and Magnetic Resonance Imaging Cardiac T2*
Shau-Yin Ha, Amanda Sio-Peng Mok, Winnie Chiu-Wing Chu, Darshana Dattatray Raskalkar, Daniel Ka-Leung Cheuk, Alan Kwok-Shing Chiang, Marco Ho-Kung Ho & Godfrey Chi-Fung Chan
Pages: 323-331
Published online: 09 Oct 2009
AbstractforA Practical Chelation Protocol Based on Stratification of Thalassemic Patients by Serum Ferritin and Magnetic Resonance Imaging Cardiac T2* | Full Text | References | PDF (244.4 KB)
  • 84 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
A New Era in Iron Chelation Therapy: The Design of Optimal, Individually Adjusted Iron Chelation Therapies for the Complete Removal of Iron Overload in Thalassemia and other Chronically Transfused Patients
George J. Kontoghiorghes
Pages: 332-338
Published online: 09 Oct 2009
AbstractforA New Era in Iron Chelation Therapy: The Design of Optimal, Individually Adjusted Iron Chelation Therapies for the Complete Removal of Iron Overload in Thalassemia and other Chronically Transfused Patients | Full Text | References | PDF (91.2 KB)
  • 131 Views
  • 32 CrossRef citations
  • 0Altmetric
Article
Iron Chelation Therapy for Patients with Myelodysplastic Syndrome
Su-Peng Yeh, Yang-Sheng Yang, Chao-Yuan Yao & Ching-Tien Peng
Pages: 339-345
Published online: 09 Oct 2009
AbstractforIron Chelation Therapy for Patients with Myelodysplastic Syndrome | Full Text | References | PDF (139 KB)
  • 104 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Treatment with Deferiprone for Iron Overload Alleviates Bone Marrow Failure in a Fanconi Anemia Patient
Yu-Hsiang Chang, Chen-Fu Shaw, Kang-Hsi Wu, Kai-Hsien Hsieh, Yi-Ning Su & Pei-Jung Lu
Pages: 346-351
Published online: 09 Oct 2009
AbstractforTreatment with Deferiprone for Iron Overload Alleviates Bone Marrow Failure in a Fanconi Anemia Patient | Full Text | References | PDF (111.6 KB)
  • 93 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Effects of Chelators (Deferoxamine, Deferiprone and Deferasirox) on the Growth of Klebsiella Pneumoniae and Aeromonas Hydrophila Isolated from Transfusion-Dependent Thalassemia Patients
Godfrey Chi-Fung Chan, Shing Chan, Pak-Leung Ho & Shau-Yin Ha
Pages: 352-360
Published online: 09 Oct 2009
AbstractforEffects of Chelators (Deferoxamine, Deferiprone and Deferasirox) on the Growth of Klebsiella Pneumoniae and Aeromonas Hydrophila Isolated from Transfusion-Dependent Thalassemia Patients | Full Text | References | PDF (405.2 KB)
  • 430 Views
  • 46 CrossRef citations
  • 0Altmetric
Article
Long-Term Effects of Pamidronate in Thalassemic Patients with Severe Bone Mineral Density Deficits
Ting Fan Leung, Yvonne Chu, Vincent Lee, Frankie W.T. Cheng, Wing Kwan Leung, Matthew M.K. Shing & Chi Kong Li
Pages: 361-369
Published online: 09 Oct 2009
AbstractforLong-Term Effects of Pamidronate in Thalassemic Patients with Severe Bone Mineral Density Deficits | Full Text | References | PDF (145.2 KB)
  • 84 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Oxidative Stress, Diabetes, and Diabetic Complications
Wei Wei, Qiuju Liu, Yi Tan, Lucheng Liu, Xiaokun Li & Lu Cai
Pages: 370-377
Published online: 12 Oct 2009
AbstractforOxidative Stress, Diabetes, and Diabetic Complications | Full Text | References | PDF (230.1 KB)
  • 856 Views
  • 120 CrossRef citations
  • 0Altmetric
Article
The Role of Labile Iron in Kidney Disease and Treatment with Chelation
Sudhir V. Shah & Mohan M. Rajapurkar
Pages: 378-385
Published online: 12 Oct 2009
AbstractforThe Role of Labile Iron in Kidney Disease and Treatment with Chelation | Full Text | References | PDF (242.5 KB)
  • 153 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Risk/Benefit Assessment, Advantages Over Other Drugs and Targeting Methods in the Use of Deferiprone as a Pharmaceutical Antioxidant in Iron Loading and Non Iron Loading Conditions
George J. Kontoghiorghes, Aglaia Efstathiou, Marios Kleanthous, Yiannis Michaelides & Anita Kolnagou
Pages: 386-397
Published online: 09 Oct 2009
AbstractforRisk/Benefit Assessment, Advantages Over Other Drugs and Targeting Methods in the Use of Deferiprone as a Pharmaceutical Antioxidant in Iron Loading and Non Iron Loading Conditions | Full Text | References | PDF (161.1 KB)
  • 192 Views
  • 23 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

A Novel 165 Kb Duplication Involving the α-Globin Gene Cluster Is Identified by Low-Pass Whole Genome Sequencing in a Chinese Thalassemia Intermedia Patient
Xiaohong He et al.
Brief Report | Published online: 1 May 2024
Sickle Cell Disease in Brazil: Current Management
Aderson da Silva Araújo et al.
Review Article | Published online: 25 Apr 2024
A Novel Frameshift Mutation(HBA2:C.337delC) Associated With α-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China
Lei Pan et al.
Brief Report | Published online: 23 Apr 2024
A New δ-Globin Gene Variant: Hb A2-Yulin [δ46(CD5)Gly→Arg,HBD: C.139G > A]
Hui-Ming Lin et al.
Brief Report | Published online: 7 Mar 2024
View all latest articles